Drug StudyNotes

Ciprofloxacin (Cipro)

Ciprofloxacin (Cipro) is a fluoroquinolone used for the treatment of infections caused by susceptible gram-negative bacteria, including E. coli, P. mirabilis, K. pneumoniae, Enterobacter cloacae, P. vulgaris, P. rettgeri, M. morganii, P. aeruginosa,Citrobacter freundii, S. aureus, S. epidermidis, group D streptococci.

Indications

  • For the treatment of infections caused by susceptible gram-negative bacteria, including E. coli, P. mirabilis, K. pneumoniae, Enterobacter cloacae, P. vulgaris, P. rettgeri, M. morganii, P. aeruginosa,Citrobacter freundii, S. aureus, S. epidermidis, group D streptococci
  • Otic: Treatment of acute otitis externa
  • Treatment of chronic bacterial prostatitis
  • IV: Treatment of nosocomial pneumonia caused by Haemophilus influenzae, K. pneumoniae
  • Oral: Typhoid fever
  • Oral: STDs caused by N. gonorrheae

Contraindications and cautions

  • Contraindicated with allergy to ciprofloxacin, norfloxacin or other fluoroquinolones, pregnancy, lactation.
  • Use cautiously with renal dysfunction, seizures, tendinitis or tendon rupture associated with fluoroquinolone use

Dosages

ADULTS

  • Uncomplicated UTIs: 100–250 mg PO q 12 hr for 3 days or 500 mg PO daily (ER tablets) for 3 days.
  • Mild to moderate UTIs: 250 mg PO q 12 hr for 7–14 days or 200 mg IV q 12 hr for 7–14 days.
  • Complicated UTIs: 500 mg bid PO q 12 hr for 7–14 days or 400 mg IV q 12 hr or 1,000 mg (ER tablets) PO daily for 7–14 days.
  • Chronic bacterial prostatitis: 500 mg PO q 12 hr for 28 days or 400 mg IV q 12 hr for 28 days.
  • Infectious diarrhea: 500 mg q 12 hr PO for 5–7 days.
  • Anthrax postexposure: 500 mg PO q 12 hr for 60 days or 400 mg IV q 12 hr for 60 days.
  • Respiratory infections 500–750 mg PO or 400 mg IV q 12 hr for 7–14 days.
  • Acute sinusitis: 500 mg PO q 12 hr or 400 mg IV q 12 hr for 10 days.
  • Acute uncomplicated pyelonephritis: 1,000 mg ER tablets PO daily for 7–14 days.
  • Bone, joint, skin infections: 500–750 mg PO or 400 mg IV q 12 hr for 4–6 wk.
  • Nosocomial pneumonia: 400 mg IV q 8 hr.
  • Ophthalmic infections caused by susceptible organisms not responsive to other therapy: 1 or 2 drops per eye daily or bid or 1/2-inch ribbon of ointment into conjunctival sac tid on first 2 days, then apply 1/2-inch ribbon bid for next 5 days.
  • Acute otitis externa: 4 drops in infected ear, tid–qid.

Adverse effects

  • CNS: Headache, dizziness, insomnia, fatigue, somnolence, depression, blurred vision
  • CV: Arrhythmias, hypotension, angina
  • EENT: Dry eye, eye pain, keratopathy
  • GI: Nausea, vomiting, dry mouth, diarrhea, abdominal pain
  • HematologicElevated BUN, AST, ALT, serum creatinine and alkaline phosphatase; decreased WBC, neutrophil count, Hct
  • Other: Fever, rash

Nursing Assessment

  • History: Allergy to ciprofloxacin, norfloxacin or other quinolones; renal dysfunction; seizures; lactation
  • Physical: Skin color, lesions; orientation, reflexes, affect; mucous membranes, bowel sounds; renal and liver function tests

Nursing Interventions

  • Arrange for culture and sensitivity tests before beginning therapy.
  • Continue therapy for 2 days after signs and symptoms of infection are gone.
  • Ensure that patient is well hydrated.
  • Give antacids at least 2 hrs after dosing.
  • Monitor clinical response; if no improvement is seen or a relapse occurs, repeat culture and sensitivity.
  • Encourage patient to complete full course of therapy.

Patient Education

  • Educate patient not to touch tip of eye ointment or solution for this may contaminate the product.
  • Encourage patient to drink plenty of fluids while taking this drug.
  • Educate patient on these side effects: Nausea, vomiting, abdominal pain (eat frequent small meals); diarrhoea or constipation; drowsiness, blurring of vision, dizziness (observe caution when driving or using dangerous equipment).
  • Encourage patient to report rash, visual changes, severe GI problems, weakness, tremors.

Related Articles

Discover more from Nursing In Ghana

Subscribe to get the latest posts sent to your email.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button